Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study by Bissonnette, Robert, Vasist, Lakshmi S., Bullman, Jonathan N., Collingwood, Therese, Chen, Geng, Maeda‐Chubachi, Tomoko

Get full text

Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET by Ridler, Khanum, Gunn, Roger N, Searle, Graham E, Barletta, Julien, Passchier, Jan, Dixson, Luanna, Hallett, William A, Ashworth, Sharon, Gray, Frank A, Burgess, Clare, Poggesi, Italo, Bullman, Jonathan N, Ratti, Emiliangelo, Laruelle, Marc A, Rabiner, Eugenii A

Get full text

Pharmacokinetics and central nervous system effects of the novel dual NK1/NK3 receptor antagonist GSK1144814 in alcohol‐intoxicated volunteers by te Beek, Erik T., Hay, Justin L., Bullman, Jonathan N., Burgess, Clare, Nahon, Kimberly J., Klaassen, Erica S., Gray, Frank A., Gerven, Joop M. A.

Get full text

The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects by Nwe, Htar H., Bullman, Jonathan N., Joshi, Shashidhar M., Stylianou, Annie, Kapsi, Shiva G.

Get full text

Pharmacokinetics and central nervous system effects of the novel dual NK 1 /NK 3 receptor antagonist GSK 1144814 in alcohol‐intoxicated volunteers by te Beek, Erik T., Hay, Justin L., Bullman, Jonathan N., Burgess, Clare, Nahon, Kimberly J., Klaassen, Erica S., Gray, Frank A., van Gerven, Joop M. A.

Get full text